These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30989570)

  • 1. Interrelations of Apoptotic and Cellular Senescence Genes Methylation in Inflammatory Bowel Disease Subtypes and Colorectal Carcinoma in Egyptians Patients.
    Salama RH; Sayed ZEA; Ashmawy AM; Elsewify WA; Ezzat GM; Mahmoud MA; Alsanory AA; Alsanory TA
    Appl Biochem Biotechnol; 2019 Sep; 189(1):330-343. PubMed ID: 30989570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors.
    Zheng S; Chen P; McMillan A; Lafuente A; Lafuente MJ; Ballesta A; Trias M; Wiencke JK
    Carcinogenesis; 2000 Nov; 21(11):2057-64. PubMed ID: 11062168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis.
    Sato F; Harpaz N; Shibata D; Xu Y; Yin J; Mori Y; Zou TT; Wang S; Desai K; Leytin A; Selaru FM; Abraham JM; Meltzer SJ
    Cancer Res; 2002 Feb; 62(4):1148-51. PubMed ID: 11861396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation of the p14ARF, RASSF1A and APC1A genes as an independent prognostic factor in colorectal cancer patients.
    Nilsson TK; Löf-Öhlin ZM; Sun XF
    Int J Oncol; 2013 Jan; 42(1):127-33. PubMed ID: 23128528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological significance of promoter hypermethylation of p14/ARF gene: relationships to p53 mutational status in Tunisian population with colorectal carcinoma.
    Chaar I; Amara S; Elamine OE; Khiari M; Ounissi D; Khalfallah T; Ben Hmida A; Mzabi S; Bouraoui S
    Tumour Biol; 2014 Feb; 35(2):1439-49. PubMed ID: 24065196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer.
    Kang MY; Lee BB; Ji YI; Jung EH; Chun HK; Song SY; Park SE; Park J; Kim DH
    Cancer; 2008 Apr; 112(8):1699-707. PubMed ID: 18327804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MGMT-B gene promoter hypermethylation in patients with inflammatory bowel disease - a novel finding.
    Mokarram P; Kavousipour S; Sarabi MM; Mehrabani G; Fahmidehkar MA; Shamsdin SA; Alipour A; Naini MA
    Asian Pac J Cancer Prev; 2015; 16(5):1945-52. PubMed ID: 25773792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy.
    Sun X; Yuan W; Hao F; Zhuang W
    Med Sci Monit; 2017 Nov; 23():5389-5395. PubMed ID: 29128865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methylation status of PCDH10 and RASSF1A gene promoters in colorectal cancer].
    Li M; Yan DG; Liu JL
    Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(6):456-9. PubMed ID: 26875923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical Profile of Tumor Suppressor Proteins RASSF1A and LATS1/2 in Relation to p73 and YAP Expression, of Human Inflammatory Bowel Disease and Normal Intestine.
    Nterma P; Panopoulou E; Papadaki-Petrou E; Assimakopoulou M
    Pathol Oncol Res; 2020 Jan; 26(1):567-574. PubMed ID: 30604274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel.
    Dulaimi E; Uzzo RG; Greenberg RE; Al-Saleem T; Cairns P
    Clin Cancer Res; 2004 Mar; 10(6):1887-93. PubMed ID: 15041703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.
    Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M
    Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
    Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
    World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients.
    Azuara D; Rodriguez-Moranta F; de Oca J; Sanjuan X; Guardiola J; Lobaton T; Wang A; Boadas J; Piqueras M; Monfort D; Galter S; Esteller M; Moreno V; Capellá G
    Inflamm Bowel Dis; 2013 Jan; 19(1):165-73. PubMed ID: 22532293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation-related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma.
    Zhang C; Guo X; Zhang L; Lu Z; Ma N; Cheng Y; Shen F; Zhang B; Wu M; Wei L
    J Surg Oncol; 2008 Nov; 98(6):462-8. PubMed ID: 18683194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of DNA Methylation at Specific Loci in Stool Samples Detects Colorectal Cancer and High-Grade Dysplasia in Patients With Inflammatory Bowel Disease.
    Kisiel JB; Klepp P; Allawi HT; Taylor WR; Giakoumopoulos M; Sander T; Yab TC; Moum BA; Lidgard GP; Brackmann S; Mahoney DW; Roseth A; Ahlquist DA
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):914-921.e5. PubMed ID: 29775793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pokemon enhances proliferation, cell cycle progression and anti-apoptosis activity of colorectal cancer independently of p14ARF-MDM2-p53 pathway.
    Zhao Y; Yao YH; Li L; An WF; Chen HZ; Sun LP; Kang HX; Wang S; Hu XR
    Med Oncol; 2014 Dec; 31(12):288. PubMed ID: 25367850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of the ARF-p53 pathway in primary angiosarcomas of the liver.
    Weihrauch M; Markwarth A; Lehnert G; Wittekind C; Wrbitzky R; Tannapfel A
    Hum Pathol; 2002 Sep; 33(9):884-92. PubMed ID: 12378512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole blood ACTB, B2M and GAPDH expression reflects activity of inflammatory bowel disease, advancement of colorectal cancer, and correlates with circulating inflammatory and angiogenic factors: Relevance for real-time quantitative PCR.
    Bednarz-Misa I; Neubauer K; Zacharska E; Kapturkiewicz B; Krzystek-Korpacka M
    Adv Clin Exp Med; 2020 May; 29(5):547-556. PubMed ID: 32424999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation in p14(ARF) is frequently observed in colorectal cancer with low-level microsatellite instability.
    Kominami K; Nagasaka T; Cullings HM; Hoshizima N; Sasamoto H; Young J; Leggett BA; Tanaka N; Matsubara N
    J Int Med Res; 2009; 37(4):1038-45. PubMed ID: 19761686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.